BioHealth News Archive
Novavax and FUJIFILM Diosynth Biotechnologies Initiate Large Scale Manufacturing of COVID-19 Vaccine Candidate
GAITHERSBURG, Md. and MORRISVILLE, N.C., July 23, 2020 /PRNewswire/ -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases,…
Read MoreAltimmune Announces Manufacturing Agreement with Vigene Biosciences for AdCOVID™, its Single Dose Intranasal Vaccine Candidate for COVID-19 Nasdaq:ALT
GAITHERSBURG, Md., July 22, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that the Company has entered into…
Read MoreUniversity System of Maryland chancellor describes rationale for fall plans | WTOP
Since May, the University System of Maryland has said that remote learning and in-person classes will return in the fall. It recently explained why…
Read MoreAlexandria LaunchLabs – Only Two Small Labs Left!
Alexandria LaunchLabs™ in Maryland, will provide fully equipped, affordable laboratory/office space with flexible lease terms, supporting infrastructure, access to amenities, and supporting services and…
Read MoreTEDCO names Troy LeMaile-Stovall as next CEO – Technical.ly Baltimore
TEDCO, Maryland’s state-backed agency that supports early-stage tech companies, has named Troy LeMaile-Stovall as its next CEO. Lemaile-Stovall, who is currently COO of the…
Read MoreIn conversation with Vaccitech CEO Enright on pandemic vaccines | FierceBiotech
Vaccitech is a spinout company from the University of Oxford's Jenner Institute, one of the oldest and most renowned vaccine research centers in the…
Read MoreCASI Pharmaceuticals Announces Proposed Public Offering Of Common Stock
ROCKVILLE, Md. and BEIJING, July 21, 2020 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics…
Read More4 Key Insights for Startups and Entrepreneurs Looking to Grow a Life Science Business · BioBuzz
Driven entrepreneurs and savvy startup leaders participated in the recent “Fueling an Innovation Ecosystem for Startups to Thrive” webinar that featured prominent connectors and…
Read MoreSerpin Pharma Receives FDA Approval for COVID-19 Clinical Investigation
Manassas, VA - On June 17, 2020, Serpin Pharma was notified by the U.S. Food and Drug Administration (FDA) that it may proceed with…
Read MoreAstraZeneca chief helps Deloitte launch Life Sciences Catalyst in Cambridge | Business Weekly | Technology News | Business news | Cambridge and the East of England
Deloitte has launched the Life Sciences Catalyst in Cambridge, a collaborative platform enabling organisations in the biotech, medtech, pharmaceutical and technology sectors, as well…
Read MoreCerecor Announces First Patient Enrolled in Multicenter Proof-of-Concept Study Evaluating CERC-002 for COVID-19 ARDS Nasdaq:CERC
ROCKVILLE, Md., July 21, 2020 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in the development and…
Read MoreWhat Safe Shopping Looks Like During the Pandemic
To limit the spread of Covid-19, the U.S. Centers for Disease Control and Prevention recommends that individuals practice social distancing. When local conditions allow…
Read MoreJHTV Contracts Team Finds Extra Meaning in Supporting Researchers’ COVID-19 Work | Johns Hopkins Technology Ventures
Virologist Andrew Pekosz has a team of 15 people working around the clock in his lab at the Johns Hopkins Bloomberg School of Public…
Read MoreBioFactura, Inc. Co-Founder, President & CEO, Darryl Sampey, PH.D., Virtually Sits Down with Rich Bendis for BioTalk
BioFactura, Inc. Co-Founder, President & CEO, Darryl Sampey, PH.D., joins BioTalk to discuss his background with the University of Maryland, the BioHealth Capital Region,…
Read MoreKidneyX Summit Announces Winners of the Redesign Dialysis Phase 2 Prize | Kidney News
Today, July 22nd, a virtual summit was hosted by KidneyX to announce the six winners of the Redesign Dialysis Phase 2 prize. The goal…
Read More